Extendicare (TSE:EXE) Q2 Earnings: Revenue Up 59.4% to C$611M

In Q2 2026, Extendicare (TSE:EXE) reported a 59.4% increase in revenue to C$611 million and a 71% rise in adjusted EBITDA to C$68.3 million. This growth was primarily driven by contributions from recent acquisitions, including CBI Home Health, which added C$145.7 million in revenue and C$18.5 million to adjusted EBITDA. The company is focused on integrating CBI, which is expected to take 18-24 months and produce C$7.4 million in annual cost synergies. For investors, this strong performance and strategic focus may enhance future profitability and operational efficiency.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.